hrp0086rfc15.6 | Late Breaking | ESPE2016
Blum Werner
, Child Christopher
, Chrousos George
, Cummings Elisabeth
, Deal Cheri
, Hasegawa Tomonobu
, Holterhus Paul-Martin
, Jia Nan
, Lawrence Sarah
, Linglart Agnes
, Loche Sandro
, Maghnie Mohamad
, Sanchez Jacobo Perez
, Polak Michel
, Predieri Barbara
, Richter-Unruh Annette
, Rosenfeld Ron
, Tajima Toshihiro
, Yeste Diego
, Yorifuji Tohru
Background: Although GHs safety profile since 1987 is good, concerns remain regarding cancer (CA) risk, and French SAGhE data indicated increased mortality and cerebrovascular disease (CVD) in certain GH-treated patients (pts).Objective and hypotheses: To evaluate key safety outcome incidence in GH-treated pts of all short stature diagnoses (dx) who participated in GeNeSIS (19992015, 30 countries).Methods: Pt history/ca...